Bladder Chemotherapy Responders

Authors

Garraway, Levi A.

Rosenberg, Jonathan Eric

Description

Description from dbGaP: "Cisplatin-based chemotherapy is the standard of care for patients with muscle invasive urothelial carcinoma. Pathologic downstaging to pT0/pTis after neoadjuvant cisplatin-based chemotherapy is associated with improved survival, and some patients with metastatic disease achieve complete responses to these therapies. However, the molecular determinants of cisplatin response...

Subject

Cisplatin

Drug Therapy

Exome Sequencing

Neoplasm Metastasis

Urinary Bladder Neoplasms

Access Rights

Application Required